Abstract:Abstract Study question To investigate the efficacies of three cycle regimens in women receiving frozen embryo transfer with a history of cesarean section(CS). Summary answer In women undergoing frozen embryo transfer with a history of CS, hormone replacement therapy for endometrial preparation was associated with a higher early miscarriage rate. What is known already Rates of CS are rising worldwide. Many women with a history of a CS delivery conceived through assisted reproductive technology (ART) are in need of frozen embryo transfer (FET) for their second progeny. Various protocols for endometrium preparation have been used to provide an optimal uterine environment for the transfer of thawed embryos, but the evidence supporting the superiority of one protocol over another is insufficient. Study design, size, duration A retrospective cohort study of patients (N = 6,159) with a history of CS who fulfilled the inclusion criteria were enrolled in the study from January 2014 to December 2019 at the CITIC-Xiangya Hospital of Reproduction and Genetics. Participants/materials, setting, methods Reproductive outcomes of patients in the natural cycle （NC） (n = 4,306) versus hormone replacement therapy（HRT） (n = 1,007) versus gonadotropin-releasing hormone agonist （GnRH-a） + HRT groups (n = 846) were compared. Multiple logistic regression analyses were performed to investigate the potential confounding factors. Main results and the role of chance The unadjusted odds of the miscarriage rate of singleton pregnancies were also significantly higher in the hormone replacement therapy compared with the natural cycle (25.5% versus 20.4%, respectively). After adjusting for possible confounding factors, the early miscarriage rate and the miscarriage rate of singleton pregnancies remained significantly higher in the hormone replacement therapy than the natural cycle. The clinical pregnancy rates in the hormone replacement therapy, hormone replacement therapy and treatment with gonadotropin-releasing hormone agonist of women with a history of cesarean section was 48.8%, 48% and 47.1%, respectively, and the live birth rates were 37%, 34.1% and 35.7%, respectively. Limitations, reasons for caution This study is limited by its retrospective design. Furthermore, the detailed ultrasound information on uterine myometrial defects, complications related to CS and the number of previous CSs were unavailable in our study. Another limitation is that pregnancy-related complications and neonatal outcomes were not analyzed. Wider implications of the findings Our study could help physicians improve their understanding of the impact of different protocols on pregnancy outcomes in patients with a history of CS. Prospective randomized trials should be conducted to assess the efficacy of endometrial preparation protocols for FET in women with a history of CS. Trial registration number not applicable

Impacts of Cyclosporin A on Clinical Pregnancy Outcomes of Patients with a History of Unexplained Transfer Failure: a Retrospective Cohort Study

Improved Pregnancy Outcomes of Cyclosporine A on Patients with Unexplained Repeated Implantation Failure in IVF/ICSI Cycles: A Retrospective Cohort Study

P-407 Pregnancy outcomes of different endometrial preparation in patients with a history of cesarean section

Short‐term Cyclosporin A Treatment Improves Pregnancy Outcomes in Patients with Unexplained Pregnancy Loss: A Prospective, Open‐label, Observational Study

Cyclosporin a improves pregnancy outcome by promoting functions of trophoblasts and inducing maternal tolerance to the allogeneic fetus in abortion-prone matings in the mouse.

Corticosteroid therapy in assisted reproduction - immune suppression is a faulty premise.

Cyclosporin A improves murine pregnancy outcome in abortion-prone matings: involvement of CD80/86 and CD28/CTLA-4.

PREGNANCY OUTCOMES IN FEMALE PATIENTS EXPOSING TO CYCLOSPORIN VERSUS TACROLIMUS AS PRIMARY IMMUNOSUPPRESSION AFTER SOLID ORGAN TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

Effects of Cyclosporin A on the Peripheral CD4+CD25+T Cells and the Outcomes of Gestation in Abortion-Prone Matings

Immunosuppressants in women with repeated implantation failure in assisted reproductive techniques: a systematic review and meta-analysis

Cyclosporine A inducing expansion of the CD4+CD25+Foxp3+ regulatory T cells and peripheral materno-fetal immune tolerance in abortion-prone matings

The Favorable Modulation of Cyclosporin A on the Biological Behaviors of Trophoblast Cells

Cyclosporine A improves pregnancy outcomes in women with recurrent pregnancy loss and elevated Th1/Th2 ratio

The Regulation of Cyclosporin A on the Ratio of IL-10 to IFN-γ at Human Maternal-Fetal Interface

Cyclosporine A Improves Adhesion and Invasion of Mouse Preimplantation Embryos Via Upregulating Integrin Β3 and Matrix Metalloproteinase-9.

Cyclosporin A Increases Expression of Matrix Metalloproteinase 9 and 2 and Invasiveness in Vitro of the First-Trimester Human Trophoblast Cells Via the Mitogen-Activated Protein Kinase Pathway

Effects of cyclosporine A on proliferation, invasion and migration of HTR-8/SVneo human extravillous trophoblasts

Cyclosporin A increases expression of matrix metalloproteinase 9 and 2 and invasiveness in vitro of the first-trimester human trophoblast cells via MAPK pathway

[Effect of Cyclosporine A on the Trophoblast Cell Secretion of Interleukin-10 and Interferon-Gamma in Early Pregnancy].

The influence of immunosuppressants on the fertility of males who undergo renal transplantation and on the immune function of their offspring.

#276 : Impact of Previous Cesarean Delivery on Pregnancy and Neonatal Outcomes of Subsequent in Vitro Fertilization/Intracytoplasmic Sperm Microinjection and Single Frozen-Thawed Embryo Transfer